Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Dec 26, 2025

Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases
07:46

Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases

Published on: October 6, 2023

1.3K

Extracellular vesicle therapy for retinal diseases.

Ben Mead1, Stanislav Tomarev2

  • 1School of Optometry and Vision Sciences, Cardiff University, Cardiff, CF24 4HQ, UK.

Progress in Retinal and Eye Research
|March 15, 2020
PubMed
Summary

Extracellular vesicles (EVs) show therapeutic potential for retinal diseases. These cell-secreted vesicles can deliver therapeutic cargo, offering a promising alternative to cell therapies for eye conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Small extracellular vesicles promote cell survival and neuritogenesis in vitro in a manner dependent on dosage and cell of origin.

Scientific reports·2026
Same author

Hopx(+) optic nerve head-astrocytes counter neuronal stress and glaucoma damage.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Studies of mice with a large deletion of the ARPKD-associated <i>Pkhd1</i> locus likely explain its GWAS association with glaucoma in humans.

bioRxiv : the preprint server for biology·2026
Same author

Extracellular vesicle-mediated delivery of miR-181a-3p confers neuroprotection to degenerating retinal ganglion cells.

Experimental eye research·2026
Same author

Circulating membrane aminophospholipids contribute to thrombotic risk in rheumatoid arthritis.

Journal of lipid research·2025
Same author

Extracellular vesicles in the eye: from biomarkers and mediators of disease, to potential therapeutics.

Experimental eye research·2025

Area of Science:

  • Cell Biology
  • Ophthalmology
  • Biomedical Engineering

Background:

  • Extracellular vesicles (EVs), including exosomes and microvesicles, are released by cells and transport biomolecules like mRNA, miRNA, lipids, and proteins.
  • EVs mediate intercellular communication and are implicated in disease progression and as potential biomarkers.
  • Recent research explores EVs as a therapeutic alternative to paracrine-acting cell therapies.

Purpose of the Study:

  • To review current research on the therapeutic efficacy of EVs in retinal disease models.
  • To highlight the potential of EVs as a novel treatment strategy for ocular conditions.
  • To identify future research directions for EV-based retinal therapies.

Main Methods:

  • Literature review of studies investigating EV delivery to the eye.
Keywords:
ExosomesExtracellular vesiclesGlaucomaMesenchymal stem cellsOptic nerve crushRetina

More Related Videos

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
06:48

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Published on: August 7, 2015

22.0K
Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye
06:10

Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye

Published on: March 30, 2020

8.3K

Related Experiment Videos

Last Updated: Dec 26, 2025

Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases
07:46

Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases

Published on: October 6, 2023

1.3K
Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
06:48

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Published on: August 7, 2015

22.0K
Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye
06:10

Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye

Published on: March 30, 2020

8.3K
  • Analysis of therapeutic effects in various animal models of retinal disease.
  • Evaluation of EV cargo and mechanisms of action in ocular tissues.
  • Main Results:

    • Studies demonstrate significant therapeutic effects of intraocular EV delivery in multiple retinal disease models.
    • EVs have shown promise in improving visual function and reducing disease pathology.
    • The retina serves as an accessible site for testing cell-based therapies, including EVs.

    Conclusions:

    • EVs represent a promising cell-free therapeutic approach for retinal diseases.
    • Further research is warranted to optimize EV-based therapies for clinical application in ophthalmology.
    • EVs offer a versatile platform for treating a range of eye conditions due to their cargo-carrying and cell-communication capabilities.